ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,274, issued on March 17, was assigned to BACHEM HOLDING AG (Bubendorf, Switzerland).
"Manufacture of glucagon peptides" was invented by Ralf Eisenhuth (Basel, Switzerland), Guenther Loidl (Rheinfelden, Germany), Daniel Samson (Basel, Switzerland) and Ralph O. Schoenleber (Lupsingen, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to a method of purifying a glucagon peptide, the method comprising a two dimensional reversed phase high performance liquid chromatography protocol, wherein the first step is carried out at using a mobile phase comprising a triethylammonium phosphate (TEAP) buffer and acetonitrile, a...